IRRAS strengthens position in neurocritical care by acquiring proprietary assets, including four US FDA-cleared products
- Assets complement IRRAflow® and support positioning as a leading company in the space- Sales of the acquired products will be initiated in the US in Q3- Acceleration of IRRAS’ product development plans and significant cost savings Stockholm, May 7, 2019 – IRRAS AB (Nasdaq First North Premier: IRRAS), a medical technology company focused on commercializing innovative solutions for neurocritical care, announced today it has acquired the assets of InnerSpace Neuro Solutions Inc. with immediate effect. These include proprietary single and multi-lumen cranial access bolts, parenchymal